Test code(s) 7788

References

  1. Fung MK, Eder AF, Spitalnik SL, et al, eds. Technical Manual. 19th ed. Bethesda, MD: American Association of Blood Banks; 2017.
  2. Bowman J. Thirty-five years of Rh prophylaxis. Transfusion. 2003;43(12):1661-1666. doi:10.1111/j.0041-1132.2003.00632.x
  3. Sandler SG, Roseff S, Dormen RE, et al, for the CAP Transfusion Medicine Resource Committee. Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the comprehensive transfusion medicine survey of the College of American Pathologists. Arch Pathol Lab Med. 2014;138(5):620-625. doi:10.5858/arpa.2013-0141-CP
  4. Sandler SG, Flegel WA, Westhoff CM, et al. It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. Transfusion. 2015;55(3):680-689. doi:10.1111/trf.12941
  5. Haspel RL, Westhoff CM. How do I manage Rh typing in obstetric patients? Transfusion. 2015;55(3):470-474. doi:10.1111/trf.12995

 

This FAQ is provided for informational purposes only and is not intended as medical advice. A clinician’s test selection and interpretation, diagnosis, and patient management decisions should be based on his/her education, clinical expertise, and assessment of the patient.

 

Document FAQS.111 Version: 2
Version 2 Effective: 06/19/2020 to present
Version 1 Effective: 05/30/2019 to 06/19/2020
Version 0 Effective: 08/21/2013 to 05/30/2019